Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Dacarbazine/doxorubicin/vinblastine

Cardiac dysfunction: case report.

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kinoshita T, et al. Activation recovery interval as an electrocardiographic repolarization index to detect doxorubicin-induced cardiotoxicity. Journal of Cardiology 82: 473-480, No. 6, Dec 2023. Available from: URL: http://dx.doi.org/10.1016/j.jjcc.2023.07.006 Kinoshita T, et al. Activation recovery interval as an electrocardiographic repolarization index to detect doxorubicin-induced cardiotoxicity. Journal of Cardiology 82: 473-480, No. 6, Dec 2023. Available from: URL: http://​dx.​doi.​org/​10.​1016/​j.​jjcc.​2023.​07.​006
Metadaten
Titel
Dacarbazine/doxorubicin/vinblastine
Cardiac dysfunction: case report.
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-49510-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

AZD-1222

Case report

Sintilimab

Case report

Multiple drugs

Case report

Immunotherapies

Case report

Multiple drugs

Case report

Ranibizumab